Skip to content

CorMedix CRMD Change in Inventories

Change in Inventories at other companies

Pfizer logo
PfizerPFE
-$140.25M-166%
Merck & Co. logo
Merck & Co.MRK
$295M+41.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$22.66M+114%
ITG
Integer HoldingsITGR
$32.39M+321%
IAR
Integra LifeSciencesIART
$4.33M-68.4%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
-$15.8M-818%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's change in inventories?
CorMedix (CRMD) reported change in inventories of $1.02M in Q1 2026.
How has CorMedix's change in inventories changed year-over-year?
CorMedix's change in inventories increased by 1006.3% year-over-year, from -$112K to $1.02M.
What is the long-term trend for CorMedix's change in inventories?
Over 4 years (2021 to 2025), CorMedix's change in inventories has grown at a 121.1% compound annual growth rate (CAGR), from -$145.46K to $3.48M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.